Clinical Trial Update: High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing high-dose multivitamins to placebo for preventing recurrence of bladder cancer after early-stage disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• High-Dose Multivitamin Supplement

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED